We use cookies for a better user experience. Read our Privacy Policy

I Agree

Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy Market (Mode: Slow Continuous Ultrafiltration, Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, and Continuous Venovenous Hemodiafiltration) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Continuous Renal Replacement Therapy Market Outlook 2031

  • The global industry was valued at US$ 1.2 Bn in 2021
  • It is projected to grow at a CAGR of 7.5% from 2022 to 2031 and reach more than US$ 2.5 Bn by the end of 2031

Analysts’ Viewpoint

Incorporation of nanotechnology, sorbent-based techniques, and water-saving strategies is the key trend in the continuous renal replacement therapy (CRRT) ecosystem. Nanotechnology is anticipated to enhance the portability of future devices. Rise in acute kidney injury diseases, increase in patient pool, advancements in technology, surge in geriatric population, growth in investments, and surge in number of dialysis centers are likely to fuel market development.

Technological advances in continuous renal replacement therapies is likely to present significant opportunities for market expansion in the next few years. Constant need for effective follow-up among patients has induced manufacturers to develop innovative artificial intelligence (AI) technology and sensors, which can be used in ICUs to predict which patients are at high risk of imminent deterioration.

Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy Market Introduction

CRRT is a preferred modality for managing the hemodynamic status of patients suffering from acute kidney injury. Patients with acute renal failure and those experiencing complications, such as imperfections or multiple organ failure in their circulatory systems that include edema and cardiac insufficiency, are also treated using CRRT systems. Other complications where these systems are used include postoperative liver failure, fulminant hepatitis, serve acute pancreatitis, and multiple organ failure.

Request a sample to get extensive insights into the Continuous Renal Replacement Therapy Market

Rise in Prevalence of Chronic Kidney Disease (CKD) to Drive Industry Progress

The global continuous renal replacement therapy market size is driven by the increase in global geriatric population. This population is more prone to chronic diseases such as chronic kidney disease (CKD). According to the United Nations (UN), the global geriatric population (65 years or above) stood at 703 million in 2019. The number is projected to double to reach 1.5 billion by 2050. According to estimates from researchers at Johns Hopkins University, more than 50% of individuals over the age of 75 are believed to be afflicted with kidney disease. Kidney disease has also been found to be more prevalent in people over the age of 60 compared to the rest of the general population.

According to Centers for Disease Control and Prevention (CDC) estimates, CKD is more common in individuals aged 65 years or older (38%) than in people aged 45–64 years (12%) or 18–44 years (6%). CKD is slightly more common in women (14%) than men (12%). The CDC stated that more than one in seven (15%) of the U.S. adults, or 37 million patients, are estimated to have CKD currently.

Chronic kidney disease has been recognized as a leading public health issue worldwide. The global estimated prevalence of CKD is 13.4% (11.7%–15.1%), and patients with end-stage kidney disease (ESKD) needing renal replacement therapy are estimated between 4.90 million and 7.08 million. The global prevalence of CKD stood at 9.1%, which was about 700 million cases, in 2017. CKD is a major public health issue in low- and middle-income countries (LMICs). Its prevalence has been rapidly increasing in LMICs, particularly in Asia.

Increase in Number of Dialysis Centers Fueling Continuous Renal Replacement Therapy Market

Rise in number of dialysis centers is likely to drive the global continuous renal replacement therapy business during the forecast period. Growth in the market can be ascribed to the rise in prevalence of acute kidney injury (AKI), presence of large number of hospitals in the U.S., and well-developed healthcare infrastructure.

Fresenius Medical Care owned and managed around 3,928 dialysis clinics in 2018 as against 3,752 dialysis clinics in 2017. According to American Hospital Association, the U.S had 5,141 community hospitals, 625 nonfederal psychiatric hospitals, and 208 federal government hospitals in 2021.

According to the Centers for Disease Control and Prevention, nearly 786,000 people in the U.S. were living with end-stage renal disease (ESRD) in 2021, with 71% on dialysis and 29% with a kidney transplant. Thus, rise in prevalence of end-stage renal disease has led to an increase in number of dialysis clinics and treatment centers.

Leading players in the industry are undertaking initiatives to reach maximum ESRD patients across all regions by increasing the number of dialysis centers. For instance, B. Braun Melsungen AG alone has more than 300 centers in Europe, Africa, and Asia Pacific. On World Kidney Day on March 9, 2017, Fresenius Medical Care launched a brand new Asia Pacific-wide corporate social responsibility initiative through a series of public awareness events reaching 6,600 children, parents, and caretakers as well as media, key renal health partners, and governments.

Request a custom report on Continuous Renal Replacement Therapy Market

Growth in Application Augmenting Continuous Venovenous Hemofiltration Segment

In terms of mode, the global market has been classified into slow continuous ultrafiltration (SCUF), continuous venovenous haemofiltration (CVVH), continuous venovenous haemodialysis (CVVHD), and continuous venovenous haemodiafiltration (CVVHDF). The continuous venovenous haemofiltration segment held major share during the forecast period. CVVHD is a short term effective temporary treatment for patients suffering from acute or chronic renal failure.

According to an article published by the American Society of Nephrology in 2019, congestive heart failure, which accounts for around 8.0% of all-cause mortality in patients with CKD stages 4 and 5, is directly linked to fluid overload. This is likely to increase the usage of CVVH treatment.

High Volume Sales Bolstering Disposables Segment

Based on product, the global continuous renal replacement therapy market has been segregated into dialysate & replacement fluids, disposables, and systems. The disposables segment has been split into bloodline sets, hemofilters, and other disposables.

The disposables segment is likely to witness strong growth in the next few years, owing to high volume sales of disposables and optimal usage of bloodline sets, hemofilters, and tubing in continuous dialysis procedures. The hemofilters sub-segment held the largest share of the disposables segment in 2021. The trend is expected to continue in the near future.

Regional Analysis

As per continuous renal replacement therapy market trends, Europe is projected to account for a leading share during the forecast period owing to the increase in incidence of acute kidney injury and favorable reimbursement policies in the region. Presence of key players, well-established research & development infrastructure, and strong government funding for CRRT for critically ill patients are likely to be other major business catalysts in the region in the next few years.

The market in Asia Pacific is projected to expand at a rapid pace during the forecast period due to strong economic growth, rise in health care infrastructure, increase in geriatric population, and surge in investments for developing advanced CRRT products. Initiatives by local governments of countries to attain self-sufficiency in manufacturing renal replacement devices are likely to be key market catalysts in Middle East & Africa and Latin America.

Analysis of Key Players

This report provides profiles of leading players operating in the global continuous renal replacement therapy market. These include Baxter International, Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, B. Braun Melsungen AG, Medica SPA, INFOMED SA, Medtronic, and Toray Medical Company Limited (Toray Industries, Inc.). These players are focused on adopting organic and inorganic growth strategies to strengthen their product portfolio to improve patient healthcare. Companies are focusing on increasing their geographical footprint through mergers & acquisitions and investment in research & development activities in order to remain competitive in the business.

Key Developments in Continuous Renal Replacement Therapy Industry

  • In May 2021, Baxter International, Inc. announced the launch of PrisMax 2 worldwide, the most recent version of its next-generation platform. PrisMax 2 is developed to help hospitals meet the special demands of intensive care unit (ICU), while simplifying the transfer of organ support along with CRRT.
  • In February 2019, Fresenius Medical Care acquired NXStage Medical, Inc., a home dialysis product manufacturer

Leading players have been profiled in the market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.

Global Continuous Renal Replacement Therapy Market Snapshot

Attribute

Detail

Size in 2021

US$ 1.2 Bn

Forecast (Value) in 2031

More than US$ 2.5 Bn

Compound Annual Growth Rate (CAGR)

7.5%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Mode
    • Slow Continuous Ultrafiltration (SCUF)
    • Continuous Venovenous Hemofiltration (CVVHF)
    • Continuous Venovenous Hemodialysis (CVVHD)
    • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • Product
    • Dialysate & Replacement Fluids
    • Disposables
    • Systems
  • Therapy
    • Renal
    • Non-renal
    • Combination
  • End-user
    • Hospitals
    • Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Baxter International, Inc.
  • Nipro Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Medica SPA
  • INFOMED SA
  • Medtronic
  • Toray Medical Company Limited (Toray Industries, Inc.)

Customization Scope

Available upon request

Pricing

Available upon request

Continuous Renal Replacement Therapy Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global continuous renal replacement therapy market in 2021?

The industry was valued at US$ 1.2 Bn in 2021

How big will the business be in 2031?

It is projected to reach more than US$ 2.5 Bn by 2031

What will be the CAGR during the forecast period?

The market is anticipated to grow at a CAGR of 7.5% from 2022 to 2031

Which are the prominent trends that affect sector growth?

Increase in incidence of acute kidney injury, rapidly aging population with increase in co-morbidities, rise in number of dialysis centers across the world, and shift in government focus toward providing better health care facilities

Who are the prominent players in the continuous renal replacement therapy industry?

Baxter International, Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, B. Braun Melsungen AG, Medica SPA, INFOMED SA, Medtronic, and Toray Medical Company Limited (Toray Industries, Inc.)

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Continuous Renal Replacement Therapy Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

    5.1. Incidence of Acute Kidney Injury Across the Globe

    5.2. Rise in Prevalence of Diabetes and Hypertension

    5.3. Reimbursement Scenario by Region/globally

    5.4. Regulatory Scenario by Region/globally

    5.5. Recent Technological Developments in Continuous Renal Replacement Therapy

    5.6. Development of CRRT System for Pediatric Patients

    5.7. Key Mergers & Acquisitions

6. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by Mode

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Mode, 2017–2031

        6.3.1. Slow Continuous Ultrafiltration (SCUF)

        6.3.2. Continuous Venovenous Hemofiltration (CVVHF)

        6.3.3. Continuous Venovenous Hemodialysis (CVVHD)

        6.3.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

    6.4. Market Attractiveness Analysis, by Mode

7. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by Product

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Product, 2017–2031

        7.3.1. Dialysate & Replacement Fluids

        7.3.2. Disposables

            7.3.2.1. Bloodline Sets

            7.3.2.2. Hemofilters

            7.3.2.3. Other Disposables

        7.3.3. Systems

    7.4. Market Attractiveness Analysis, by Product

8. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by Therapy

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Therapy, 2017–2031

        8.3.1. Renal

        8.3.2. Non-renal

        8.3.3. Combination

    8.4. Market Attractiveness Analysis, by Therapy

9. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Hospitals

        9.3.2. Clinics

        9.3.3. Others

    9.4. Market Attractiveness Analysis, by End-user

10. Global Continuous Renal Replacement Therapy Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Region

11. North America Continuous Renal Replacement Therapy Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Mode, 2017–2031

        11.2.1. Slow Continuous Ultrafiltration (SCUF)

        11.2.2. Continuous Venovenous Hemofiltration (CVVHF)

        11.2.3. Continuous Venovenous Hemodialysis (CVVHD)

        11.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

    11.3. Market Value Forecast, by Product, 2017–2031

        11.3.1. Dialysate & Replacement Fluids

        11.3.2. Disposables

            11.3.2.1. Bloodline Sets

            11.3.2.2. Hemofilters

            11.3.2.3. Other Disposables

        11.3.3. Systems

    11.4. Market Value Forecast, by Therapy, 2017–2031

        11.4.1. Renal

        11.4.2. Non-renal

        11.4.3. Combination

    11.5. Market Value Forecast, by End-user, 2017–2031

        11.5.1. Hospitals

        11.5.2. Clinics

        11.5.3. Others

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Mode

        11.7.2. By Product

        11.7.3. By Therapy

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Continuous Renal Replacement Therapy Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Mode, 2017–2031

        12.2.1. Slow Continuous Ultrafiltration (SCUF)

        12.2.2. Continuous Venovenous Hemofiltration (CVVHF)

        12.2.3. Continuous Venovenous Hemodialysis (CVVHD)

        12.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

    12.3. Market Value Forecast, by Product, 2017–2031

        12.3.1. Dialysate & Replacement Fluids

        12.3.2. Disposables

            12.3.2.1. Bloodline Sets

            12.3.2.2. Hemofilters

            12.3.2.3. Other Disposables

        12.3.3. Systems

    12.4. Market Value Forecast, by Therapy, 2017–2031

        12.4.1. Renal

        12.4.2. Non-renal

        12.4.3. Combination

    12.5. Market Value Forecast, by End-user, 2017–2031

        12.5.1. Hospitals

        12.5.2. Clinics

        12.5.3. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Mode

        12.7.2. By Product

        12.7.3. By Therapy

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Continuous Renal Replacement Therapy Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Mode, 2017–2031

        13.2.1. Slow Continuous Ultrafiltration (SCUF)

        13.2.2. Continuous Venovenous Hemofiltration (CVVHF)

        13.2.3. Continuous Venovenous Hemodialysis (CVVHD)

        13.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

    13.3. Market Value Forecast, by Product, 2017–2031

        13.3.1. Dialysate & Replacement Fluids

        13.3.2. Disposables

            13.3.2.1. Bloodline Sets

            13.3.2.2. Hemofilters

            13.3.2.3. Other Disposables

        13.3.3. Systems

    13.4. Market Value Forecast, by Therapy, 2017–2031

        13.4.1. Renal

        13.4.2. Non-renal

        13.4.3. Combination

    13.5. Market Value Forecast, by End-user, 2017–2031

        13.5.1. Hospitals

        13.5.2. Clinics

        13.5.3. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Mode

        13.7.2. By Product

        13.7.3. By Therapy

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Continuous Renal Replacement Therapy Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Mode, 2017–2031

        14.2.1. Slow Continuous Ultrafiltration (SCUF)

        14.2.2. Continuous Venovenous Hemofiltration (CVVHF)

        14.2.3. Continuous Venovenous Hemodialysis (CVVHD)

        14.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

    14.3. Market Value Forecast, by Product, 2017–2031

        14.3.1. Dialysate & Replacement Fluids

        14.3.2. Disposables

            14.3.2.1. Bloodline Sets

            14.3.2.2. Hemofilters

            14.3.2.3. Other Disposables

        14.3.3. Systems

    14.4. Market Value Forecast, by Therapy, 2017–2031

        14.4.1. Renal

        14.4.2. Non-renal

        14.4.3. Combination

    14.5. Market Value Forecast, by End-user, 2017–2031

        14.5.1. Hospitals

        14.5.2. Clinics

        14.5.3. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Mode

        14.7.2. By Product

        14.7.3. By Therapy

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East & Africa Continuous Renal Replacement Therapy Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Mode, 2017–2031

        15.2.1. Slow Continuous Ultrafiltration (SCUF)

        15.2.2. Continuous Venovenous Hemofiltration (CVVHF)

        15.2.3. Continuous Venovenous Hemodialysis (CVVHD)

        15.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)

    15.3. Market Value Forecast, by Product, 2017–2031

        15.3.1. Dialysate & Replacement Fluids

        15.3.2. Disposables

            15.3.2.1. Bloodline Sets

            15.3.2.2. Hemofilters

            15.3.2.3. Other Disposables

        15.3.3. Systems

    15.4. Market Value Forecast, by Therapy, 2017–2031

        15.4.1. Renal

        15.4.2. Non-renal

        15.4.3. Combination

    15.5. Market Value Forecast, by End-user, 2017–2031

        15.5.1. Hospitals

        15.5.2. Clinics

        15.5.3. Others

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1. By Mode

        15.7.2. By Product

        15.7.3. By Therapy

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (By Tier and Size of companies)

    16.2. Market Position By Company (2021)

    16.3. Company Profiles

        16.3.1. Baxter International, Inc.

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. SWOT Analysis

            16.3.1.4. Strategic Overview

        16.3.2. Nipro Corporation

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. SWOT Analysis

            16.3.2.4. Strategic Overview

        16.3.3. Asahi Kasei Corporation

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. SWOT Analysis

            16.3.3.4. Strategic Overview

        16.3.4. B. Braun Melsungen AG

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. SWOT Analysis

            16.3.4.4. Strategic Overview

        16.3.5. Medica SPA

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. SWOT Analysis

            16.3.5.4. Strategic Overview

        16.3.6. INFOMED SA

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. SWOT Analysis

            16.3.6.4. Strategic Overview

        16.3.7. Medtronic

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. SWOT Analysis

            16.3.7.4. Strategic Overview

        16.3.8. Toray Medical Company Limited (Toray Industries, Inc.)

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. SWOT Analysis

            16.3.8.4. Strategic Overview

List of Tables

Table 01: Opportunity Map, by Mode, 2021

Table 02: Market Opportunity Map, by Product Type, 2021

Table 03: Opportunity Map, by Therapy, 2021

Table 04: Opportunity Map, by End-user, 2021

Table 05: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

Table 06: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 07: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

Table 08: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

Table 09: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 10: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Region, 2017–2031

Table 11: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

Table 12: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 13: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

Table 14: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

Table 15: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country, 2017–2031

Table 17: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

Table 18: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

Table 20: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

Table 21: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 22: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 23: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

Table 24: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 25: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

Table 26: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

Table 27: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 28: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 29: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

Table 30: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 31: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

Table 32: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

Table 33: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 34: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 35: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Mode, 2017–2031

Table 36: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 37: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

Table 38: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Therapy, 2017–2031

Table 39: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 40: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

List of Figures

Figure 01: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) and End-user, by Region, 2021 and 2031

Figure 02: Global Continuous Renal Replacement Therapy Market Share Analysis, by Region, 2021

Figure 03: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, 2017–2031

Figure 04: Global Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021

Figure 05: Global Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021

Figure 06: Global Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021

Figure 07: Global Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021

Figure 08: Global Continuous Renal Replacement Therapy Market Revenue Share, by Region, 2021

Figure 09: Global Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

Figure 10: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

Figure 11: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by SCUF, 2017–2031

Figure 12: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CVVH, 2017–2031

Figure 13: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CVVHD, 2017–2031

Figure 14: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CVVHDF, 2017–2031

Figure 15: Global Continuous Renal Replacement Therapy Market Revenue Share Analysis, by Product, 2021 and 2031

Figure 16: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 17 A: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Dialysate & Replacement Fluids, 2017–2031

Figure 17 B: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Disposables, 2017–2031

Figure 18: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Systems, 2017–2031

Figure 19: Global Continuous Renal Replacement Therapy Market Revenue Share Analysis, by Therapy, 2021 and 2031

Figure 20: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 21: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Renal, 2022–2031

Figure 22: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) ) Forecast , by Non-renal, 2022–2031

Figure 23: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast, by Combination, 2022–2031

Figure 24: Global Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

Figure 25: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 26: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) ) Forecast and Y-o-Y Growth (%), by Hospitals, 2022–2031

Figure 27: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) ) Forecast and Y-o-Y Growth (%), by Clinics, 2022–2031

Figure 28: Global Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2022–2031

Figure 29: Global Continuous Renal Replacement Therapy Market Revenue Share, by Region, 2021 and 2031

Figure 30: Global Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Region, 2022–2031

Figure 31: North America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 32: North America Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

Figure 33: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

Figure 34: North America Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

Figure 35: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 36: North America Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

Figure 37: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 38: North America Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

Figure 39: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 40: North America Continuous Renal Replacement Therapy Market Revenue Share, by Country, 2021 and 2031

Figure 41: North America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country, 2022–2031

Figure 42: Europe Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 43: Europe Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

Figure 44: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

Figure 45: Europe Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

Figure 46: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 47: Europe Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

Figure 48: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 49: Europe Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

Figure 50: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 51: Europe Continuous Renal Replacement Therapy Market Revenue Share, by Country/Sub-region, 2021 and 2031

Figure 52: Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 53: Asia Pacific Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 54: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

Figure 55: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

Figure 56: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

Figure 57: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 58: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

Figure 59: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 60: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

Figure 61: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 62: Asia Pacific Continuous Renal Replacement Therapy Market Revenue Share, by Country/Sub-region, 2021 and 2031

Figure 63: Asia Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 64: Latin America Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 65: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

Figure 66: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

Figure 67: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

Figure 68: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 69: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

Figure 70: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 71: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

Figure 72: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 73: Latin America Continuous Renal Replacement Therapy Market Revenue Share, by Country/Sub-region, 2021 and 2031

Figure 74: Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 75: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 76: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by Mode, 2021 and 2031

Figure 77: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Mode, 2022–2031

Figure 78: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by Product, 2021 and 2031

Figure 79: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 80: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by Therapy, 2021 and 2031

Figure 81: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 82: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by End-user, 2021 and 2031

Figure 83: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 84: Middle East & Africa Continuous Renal Replacement Therapy Market Revenue Share, by Country/Sub-region, 2021 and 2031

Figure 85: Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

217

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved